Envestnet Asset Management Inc Genfit S.A. Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$3.15 - $4.12 $5,597 - $7,321	-1,777 Reduced 4.3%	39,568 $129,000
Q2 2023 Aug 04, 2023	SELL	$3.54 - $4.68 $475,383 - $628,472	-134,289 Reduced 76.46%	41,345 $146,000
Q1 2023 May 11, 2023	BUY	$3.93 - $4.69 $585,884 - $699,185	149,080 Added 561.42%	175,634 $720,000
Q4 2022 Feb 07, 2023	BUY	$3.53 - $4.39 $26,316 - $32,727	7,455 Added 39.03%	26,554 $116,000
Q3 2022 Nov 10, 2022	BUY	$3.26 - $4.86 $62,262 - $92,821	19,099 New	19,099 $70,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.